MedPath

Prevention of knee Osteoarthritis in Overweight Females

Not Applicable
Completed
Conditions
Osteoarthritis in overweight females
Musculoskeletal Diseases
Osteoarthritis, obesity
Registration Number
ISRCTN42823086
Lead Sponsor
Erasmus Medical Centre (Netherlands)
Brief Summary

1. 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/23429925 2. 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/24774470 3. 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/24706992 4. 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/25278062 5. 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/25891749 6. 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/25818496 7. 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/26806185 8. 2016 results in: http://www.ncbi.nlm.nih.gov/pubmed/27305950 9. 2016 results in: http://www.ncbi.nlm.nih.gov/pubmed/26866630 10. 2016 results in: http://www.ncbi.nlm.nih.gov/pubmed/26521011 11. 2016 results in: http://www.ncbi.nlm.nih.gov/pubmed/26748391 12. 2017 results in: http://www.ncbi.nlm.nih.gov/pubmed/28431145 13. 2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31300578 (added 15/07/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
407
Inclusion Criteria

Women aged 50 - 60 years who are overweight (body mass index [BMI] of 27 kg/m^2 or more)

Exclusion Criteria

Amended as of 03/12/2008: point six of the exclusion criteria has been amended as follows:
6. Contraindication for magnetic resonance (MR) imaging

Initial information at time of registration:
1. Knee osteoarthritis (OA)
2. Knee pain indicating knee OA
3. Radiological signs indicating knee OA (Kellgren-Lawrence index of 2 or more)
4. Positive for knee OA according to the American College of Rheumatology (ACR) criteria for knee OA
5. Presence of severe co-morbidity
6. Pacemaker
7. Current use of glucosamine sulphate
8. Not being able to communicate in the Dutch language

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath